Long‐Term Survival Outcomes of Concurrent Chemoradiotherapy for Postoperative High‐Risk Salivary Gland Carcinomas
The prospective cohort analyzed in this study originated from the non-ACC group enrolled in a phase 2 clinical trial (NCT02776163).
Authors
- Lulu Ye
- Wen Jiang (ORCID: https://orcid.org/0000-0003-4174-667X)
- Lu Zhang (ORCID: https://orcid.org/0000-0002-3139-2356)
- Xin Wang (ORCID: https://orcid.org/0009-0009-0444-1704)
- Yu Wang
- Shengjin Dou
- Rongrong Li
- Guopei Zhu
Institutions
- Shanghai Jiao Tong University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Shanghai Ninth People's Hospital (CN)
- Shanghai Second People's Hospital (CN)
- Shanghai Clinical Research Center (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1002/cam4.71722
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00